COVID-19 vaccines: intellectual-property challenges and transnational-legal opportunities

dc.contributor.authorRamraj, Victor V.
dc.contributor.authorGebru, Aman
dc.date.accessioned2021-04-09T21:27:06Z
dc.date.available2021-04-09T21:27:06Z
dc.date.copyrightApril 9, 2021en_US
dc.date.issued2021-04-09
dc.descriptionThis is the second event of the Relevant-talk series: critical legal theory and more. This academic discussion was hosted on April 9, 2021. Therefore, it was one of the first (if not the first) critical-legal discussions about the challenges and opportunities emerging from initiatives aiming to ensure global equitable access to COVID-19 vaccines and treatments, such as the initiative proposed by India and South Africa or COVAX.en_US
dc.description.abstractIn October 2020, India and South Africa proposed the World Trade Organization (WTO) to temporarily suspend trade-related intellectual property rights to COVID-19 vaccines and technologies. The proposal aims to ensure that not only the wealthiest countries will be able to access and afford those vaccines and technologies. After the proposal was presented, analysts claim that a “vaccine apartheid” has already been created. In response, in March 2021, Dr. Ngozi Okonjo-Iweala, Director-General of the WTO, invited countries and manufacturers to implement a framework that would provide developing countries with more opportunities to access COVID-19 technologies. On April 9, 2021, the UVic Graduate Student Law & Society Research Group hosted an academic discussion between Professor Victor V. Ramraj (University of Victoria-Faculty of Law) and Professor Aman Gebru (Duquesne University-School of Law). Both speakers 1) explained the proposal that India and South Africa presented to the WTO; 2) discussed other initiatives to facilitate access to COVID-19 vaccines and technologies like the COVAX initiative, which is co-led by the World Health Organization (WHO), CEPI, GAVI, and UNICEF; and 3) explored relevant legal, socio-economic, ethical, political, and international issues that could facilitate or restrict access to COVID-19 vaccines and technologies. Therefore, this event was one of the first (if not the first) thoughtful critical-legal discussions about the challenges and opportunities emerging from initiatives aiming to ensure global equitable access to COVID-19 vaccines and treatments, such as the initiative proposed by India and South Africa or COVAX.en_US
dc.description.reviewstatusUnrevieweden_US
dc.description.scholarlevelFacultyen_US
dc.description.sponsorshipThe UVic Graduate Student Law & Society Research Groupen_US
dc.identifier.urihttp://hdl.handle.net/1828/12842
dc.language.isoenen_US
dc.relation.ispartofseriesUVic Graduate Student Law & Society Research Group - Relevant-talk series: critical legal theory and more/ No. 2en_US
dc.rightsAttribution-NonCommercial-NoDerivs 2.5 Canada*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/ca/*
dc.subjectCOVID-19 vaccines, patent, WTO, waiver, India, South Africa, COVAX, equitable access, intellectual property, transnational law, international law, critical legal theory, developing countries, developed countriesen_US
dc.titleCOVID-19 vaccines: intellectual-property challenges and transnational-legal opportunitiesen_US
dc.typePresentationen_US
dc.typeVideoen_US

Files

Original bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
Ramraj_Victor_ V_&_Gebru_Aman_ COVID-19 vaccines intellectual-property challenges and transnational-legal opportunities.mp4
Size:
681.37 MB
Format:
Description:
Video
No Thumbnail Available
Name:
Ramraj_Victor_ V_&_Gebru_Aman_ COVID-19 vaccines intellectual-property challenges and transnational-legal opportunities.m4a
Size:
65.79 MB
Format:
Unknown data format
Description:
Audio
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2 KB
Format:
Item-specific license agreed upon to submission
Description: